Summary
Johnson & Johnson (JNJ) reported its first-quarter 2021 results on April 20, 2021, via an 8-K filing. The report primarily directs investors to an attached press release and supplementary financial data detailing sales and earnings for the period ended April 4, 2021. While the 8-K itself is brief, it serves as the official notification of the company's financial performance for the quarter, highlighting the release of these key metrics. Investors should review the accompanying press release (Exhibit 99.1) and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings (Exhibit 99.2) for a comprehensive understanding of JNJ's financial condition and operational results during the first quarter of 2021. These documents will contain the specific figures for revenue, earnings per share, and segment-level performance that are critical for investment decisions.
Key Highlights
- 1Johnson & Johnson filed an 8-K on April 20, 2021, reporting its Q1 2021 financial results.
- 2The primary purpose of the filing was to announce the company's sales and earnings for the first quarter ended April 4, 2021.
- 3Investors are directed to an attached press release (Exhibit 99.1) for detailed Q1 2021 financial performance.
- 4Supplementary sales data and condensed consolidated statements of earnings for the quarter are also provided as an exhibit (Exhibit 99.2).
- 5The filing marks the official release of JNJ's Q1 2021 financial and operational performance information.